ADVISORY/Haemacure Corporation: Media Advisory.KIRKLAND, Quebec--(BUSINESS WIRE)--Oct. 26, 1998--HAEMACURE (ME:HAE.) (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :HAE.) Haemacure Corporation will be attending the American College of Surgeons This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. 84th Annual Clinical Congress at the Orange County Convention Center The Orange County Convention Center (OCCC) is the primary public convention center in Central Florida. The large complex is located on International Drive, a major tourist area in Orlando, Florida. , in Orlando, Florida from October 26th through October 29th. Haemacure, a leading-edge biosurgical company, is involved in the development and marketing of innovative biological adhesives, biomaterials and delivery devices for the acute surgical wound care market. The Company was recently granted US co-marketing and distribution rights for Hemaseel APR(TM), the first fibrin sealant product ever approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . Mr. Marc Paquin, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Haemacure, and members of the management team, will be attending the Congress and will be available for media interviews. -0-
Date: October 26th - October 29th
Where: Orange County Convention Center
9800 International Drive
Orlando, Florida 32819
Booth: No. 1552
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion